Search Count: 24
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-07-10 Classification: SIGNALING PROTEIN Ligands: GDP, MG, A1H5U |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2023-03-01 Classification: TRANSFERASE/INHIBITOR Ligands: Y7W, SO4, GOL, BTB |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2023-03-01 Classification: TRANSFERASE/INHIBITOR Ligands: Y7W, SO4, GOL, BTB |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2021-06-02 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: URJ |
 |
Organism: Leishmania donovani
Method: ELECTRON MICROSCOPY Release Date: 2020-08-26 Classification: HYDROLASE Ligands: N2E |
 |
Leishmania Tarentolae Proteasome 20S Subunit Complexed With Lxe408 And Bortezomib
Organism: Leishmania donovani
Method: ELECTRON MICROSCOPY Release Date: 2020-08-26 Classification: HYDROLASE Ligands: BO2, N2E |
 |
Crystal Structure Of The Core Catalytic Domain Of Human O-Glcnacase Bound To Mk-8719
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.86 Å Release Date: 2019-09-18 Classification: HYDROLASE Ligands: OQ1 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-12-12 Classification: ONCOPROTEIN Ligands: GDP, MG, K9M |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2018-12-12 Classification: ONCOPROTEIN Ligands: GDP, MG, K9J |
 |
Crystal Structure Of Hiv Protease Complexed With (S)-N-(3-Fluoro-2-(2-(1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKD |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKM |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKS |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,5S)-5-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKV |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6S)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKY |
 |
Crystal Structure Of Hiv Protease Complexed With N-(2-(2-((6R,9S)-2,2-Dioxido-2-Thia-1,7-Diazabicyclo[4.3.1]Decan-9-Yl)Ethyl)-3-Fluorophenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CN4, CL |
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-Benzhydryl-2-(3-Morpholin-4-Ium-2-Ylpropylamino)-2-Oxo-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: 6EH, CL |
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-[[2-[(3S)-3-[(4-Aminophenyl)Methylamino]-4-Hydroxy-Butyl]Phenyl]Carbamoyl]-2,2-Diphenyl-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: CL, 6EG |
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-Benzhydryl-2-[2-[2-[(2R,5S)-5-(Benzylcarbamoyloxymethyl)Morpholin-2-Yl]Ethyl]Anilino]-2-Oxo-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: CL, 6EF |
 |
Crystal Structure Of Hiv Protease Complexed With [(1S)-1-[(S)-(4-Chlorophenyl)-(3,5-Difluorophenyl)Methyl]-2-[[5-Fluoro-4-[2-[(2R,5S)-5-(2,2,2-Trifluoroethylcarbamoyloxymethyl)Morpholin-4-Ium-2-Yl]Ethyl]Pyridin-1-Ium-3-Yl]Amino]-2-Oxo-Ethyl]Ammonium
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.15 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: ACT, 6EE, CL |
 |
Identification Of Lxrbeta Selective Agonists For The Treatment Of Alzheimer'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2016-04-06 Classification: SIGNALING PROTEIN Ligands: 668, PEG |